An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non–Small-Cell Lung Cancer We assessed cancer-related molecular marker test ...
Tumor markers for small cell lung cancer (SCLC) are measurable using blood tests, such as neuron-specific enolase (NSE). They can support the identification and management of cancer. Doctors use a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results